SIO_901250-22WebSocialGraphics.jpg

SIO2023 Annual Scientific Meeting Program

All Levels 100 Level 200 Level 300 Level Industry/Sponsored


The session information listed here is subject to change. This page was last updated 21 January 2023.

Thursday 19 January 2023

Time (EST)

Session Title(s)

8:30am - 6:00pm Click here to view IO Essentials Programming
1:00pm - 2:00pm

*Ablation Master Class: Liver & Kidney Ablation

Moderators: Ron Arellano, MD, Massachusetts General Hospital; Martijn Meijerink, MD, PhD, Amsterdam UMC

  • Liver: Diaphragm, Gallbladder & Bowel, Ron Arellano, MD, Massachusetts General Hospital
  • Liver: Perivascular Lesions, Martijn Meijerink, MD, PhD, Amsterdam UMC
  • Kidney: Difficult to Reach Lesions, Andrew Taylor, MD, PhD, University of California San Francisco 
  • Kidney: Collecting System Protection, AJ Gunn, MD, University of Alabama at Birmingham
2:15pm - 3:15pm

*Ablation Master Class: Lung, Adrenal & Pancreas Ablation

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Marwan Moussa, MD, Beth Israel Deaconess Medical Center

  • Lung: Pearls & Pitfalls, Frederic Deschamps, MD, PhD, Gustave Roussy
  • Lung: Chest Wall Lesions, Damian Dupuy, MD, FACR, Cape Cod Hospital
  • Adrenal Ablation: Staying Out of TroubleMarwan Moussa, MD, Beth Israel Deaconess Medical Center
  • Pancreas AblationMartijn Meijerink, MD, PhD, Amsterdam UMC
3:45pm - 4:45pm

*Ablation Master Class: MSK Pain Palliation

Moderators: Jack Jennings, MD, PhD, Washington University St. Louis; Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens; Franco Orsi, MD, European Institute of Oncology

  • Ablation Neurolysis, Neil J. Resnick, MD, Emory University
  • Appendicular Skeletal Lesions, Jack Jennings, MD, PhD, Washington University St. Louis
  • Pelvic Stabilization & Ablation, Steven Yevich, MD, MPH, MD Anderson Cancer Center
  • Vertebral Augmentation Combined with Ablation, Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens
5:00pm - 6:00pm

*Ablation Master Class: Emerging Techniques

Moderators: Afshin Gangi, MD, University Hospital of Strasbourg; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

  • Thyroid Ablation, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
  • Breast Ablation, Alan Alper Sag, MD, Duke University Medical Center
  • Prostate AblationAfshin Gangi, MD, University Hospital of Strasbourg
  • Lymph Node Ablation, Dimitrios Filippiadis MD, PhD, MSc, EBIR, University of Athens
*Ablation Master Class attendance requires an additional fee.

Friday 20 January 2023

Time (EST)

Session Title(s)

7:45am - 8:30am

Breakfast & Industry Symposium Presented by Stryker - Bone Tumor Ablation with Stryker's OptaBlate System

  • Reade De Leacy, MD, Mount Sinai
8:30am - 9:00am Break
9:00am - 10:00am

President's Welcome & Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture

  • President's Welcome, Matthew Callstrom, MD, PhD, Mayo Clinic
  • Meeting Intro & ThanksDamian Dupuy, MD, FACR, Cape Cod Hospital
  • Laudation, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
  • Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture, Prof. S. Nahum Goldberg, MD, Hadassah Hebrew University Medical Center
10:00am - 11:00am

Patient-Centered IO Care

Moderators: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

  • Whole Patient Approach to IOIsabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
  • Extending Life & Living with Chronic Cancer, Angela Laffan, NP, MSN, University of California San Francisco
  • Death & Dying: Realistic Expectations, Cristal Brown, MD, MHS, University of Texas at Austin Dell Medical School
  • Caring for Those Who Care: Families & Physicians, Janice Newsome, MD, Emory University
  • Survivorship: Patient Perspective, Lynn Lazzaro, Valley Advisors
11:00am - 11:30am

Expo Hall Break - Discovery Theater Presentation by Guerbet

HCC Managment in 2023: Moving Towards a More Targeted Treatment Delivery, Pav Najran, MD

11:30am - 12:30pm

Immuno-oncology

Moderators: Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center

  • Basics of Immunology, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Immunoadjuvants for AblationIsabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
  • Tumor DNA Research, Mark Yarchoan, MD, Johns Hopkins Univesity
  • Immunotherapy Pipeline, Gordon Cohen, MD, AstraZeneca

Advanced Glass Y90 Radioembolization

Moderators: Edward Kim, MD, Mount Sinai Health Systems; Riad Salem, MD, MBA, Northwestern University

  • Understanding the Basic Science of Glass Microspheres, Nora Tabori, MD, MedStar
  • Absorbed Dose Dosimetric Principles, Beau Toskich, MD, Mayo Clinic
  • HCC with PVT: The Past, Present & Future, Robert Lewandowski, MD, FSIR, Northwestern Medicine
  • Applying the Outcomes of EPOCH, Riad Salem, MD, MBA, Northwestern University
  • Case Discussions, All

SIO Meets International IO Societies

Moderators: Frederic Deschamps, MD, PhD, Gustave Roussy; David Breen, MD, MRCP, FRCR, University Hospitals Southampton

  • CIRSE, Laura Crocetti, MD, PhD, University of Pisa
  • JSIR, Koichiro Yamakado, MD, PHD, Hyogo College of Medicine
  • SOBRICE, Marcos Menezes, PhD, Hospital da Clinicas da Universidade de Sao Paulo
  • PAIRS, Mohammad Arabi, MD, King Abdulaziz Medical Center

12:30pm - 12:45pm Break
12:45pm - 1:30pm

Lunch & Industry Symposium Presented by Boston Scientific - State-of-the-Art Locoregional Therapies for Liver and Lung

  • Robert Suh, MD, Ronald Reagan UCLA Medical Center
  • Beau Toskich, MD, Mayo Clinic

Lunch & Industry Symposium Presented by Guerbet - Optimize Your Treatment Delivery in HCC

  • IntroductionMike Devane, MD, Greenville Memorial Hospital
  • How I Improve Selective Treatment in TARE?, Pav Najran, MD
  • How I Deliver with More Precision in DEB-TACE?, Mike Devane, MD, Greenville Memorial Hospital
1:30pm - 2:00pm

Expo Hall Afternoon Hours - Discovery Theater Presentation by Genentech

Advancement in the 1L Treatment of Unresectable or Metastatic HCC, Ripal Gandhi, MD

2:00pm - 3:00pm

State of the Art SIO Trials

Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

  • EMERALD1, Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center
  • Imaging Tumor Microenvironments SIO Grant Update, Julius Chapiro, MD, PhD, Yale University School of Medicine
  • Immunology SIO Grant Update, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
  • Lipiodol SIO Grant Update, Rony Avritscher, MD, MD Anderson Cancer Center
  • ACCLAIM, Costi Sofocleous, MD, PhD, Weill-Cornell Medical College/Memorial Sloan Kettering Cancer Center

Advanced Resin Y90 Embolization

Moderators: Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School; Marnix Lam, MD, PhD, University Medical Center Utrecht

  • Advantages of ScoutY90 Dose for Resin Radioembolization, Nima Kokabi, MD, Emory University
  • Dose-Response Thresholds for Safety and Efficacy with Resin Microspheres, Marnix Lam, MD, PhD, University Medical Center Utrecht
  • Trial Design in Resin Radioembolization: What We have Learned from SARAH, SirVeNib, SORAMIC, SIRFLOX, DoorWAY, Matthias Stechele, MD, LMU Kliniken
  • Challenging Clinical Scenarios in Advanced Resin RadioembolizationAmmar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
  • Current Findings from the RESIN Registry, Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School

3:00pm - 4:00pm

Expo Hall Networking & Oral Poster Presentations 

  • Computed Tomography-Guided Percutaneous Microwave Ablation for Renal Cell Carcinoma: Evaluation of Morphological factors affecting the outcome, Ornella Moschovaki-Zeiger, MD, "Attikon" University General Hospital of Athens/Greece
  • Safety and efficacy of histotripsy delivery through overlying gas-filled bowel in an ex vivo swine model, Meredith Kisting, MA, University of Wisconsin
  • The Diagnostic Value of Transcatheter CTHA for Intraprocedural Detection of previously unknown CRLM during Percutaneous Ablation and Impact on Treatment plan, Susan van der Lei, MD, PhD, Amsterdam UMC
4:00pm - 5:00pm

Hands-On: Ablation

Renal/Adrenal 

Moderators: Philippe Periera, MD, SLK Kliniken; Ron ArellanoMD, Massachusetts General Hospital

  • State of the Art Treatment of Stage 1 RCC: Ablative Techniques, Debra Gervais, MD, Massachusetts General Hospital
  • Know Your Real Estate: Techniques to Reduce Collateral Injuries, AJ Gunn, MD, University of Alabama at Birmingham
  • Changing Landscape of Early RCC Treatment, David Breen, MD, MRCP, FRCR, University Hospitals Southampton
  • Adrenal: Primary & Metastatic Disease, Marwan Moussa, MD, Beth Israel Deaconess Medical Center

HCC: 2023 Updates

Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard

  • Y90 Dosing/Cholangio, Zach Berman, MD, University of California San Diego
  • BCLC in Evolution, David Madoff, MD, Yale School of Medicine
  • Current Evidence for Systemic Treatment, Marina Baretti, MD, Johns Hopkins University
  • Pros & Cons of Ablative Modalities in the Liver, Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
  • Reinventing TACE: The Role of Embolics, Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
5:00pm - 5:15pm Break
5:15pm - 6:15pm

HCC/Cholangio Tumor Board

Moderators: Riad Salem, MD, MBA, Northwestern University; Muneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard

Panelists: Zach Berman, MD, University of California San Diego; David Madoff, MD, Yale School of Medicine; Marina Baretti, MD, Johns Hopkins University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Jennifer Berumen. MD, University of California San Diego; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

6:15pm - 7:30pm Opening & Founding Members Reception

Saturday 21 January 2023

Time (EST)

Session Title(s)

7:45am - 8:30am

Breakfast & Education Session - Optimal Preparation and Treatment Endpoints in cTACE

  • Sarah White, MD, MS, Medical College of Wisconsin
  • William Rilling, MD, FSIR, Medical College of Wisconsin
  • Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
  • Nicholas Fidelman, MD, University of California San Francisco
8:00am - 9:00am Expo Hall Morning Hours
9:00am - 10:00am

Y90 Radioembolization for Primary & Metastatic Liver Cancer: One Size Does Not Fit All

Moderators: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Ghassan El-Haddad, MD, Moffitt Cancer Center and Research Institute

  • Lung Shunt & Lung Dose Considerations Marnix Lam, MD, PhD, University Medical Center Utrecht
  • Multi-Compartment DosimetryGhassan El-Haddad, MD, Moffitt Cancer Center and Research Institute
  • Dosimetry in Ablative Setting: Resin versus Glass, Beau Toskich, MD, Mayo Clinic
  • Dosimetry in Non-Ablative Setting: Resin versus Glass, Nima Kokabi, MD, Emory University
  • Post-Treatment Imaging: SPECT versus PET, S. Cheenu Kappadath, PhD, MD Anderson Cancer Center
10:00am - 11:00am

Scientific Oral Abstracts

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

  • Bone Ablation with a Saline-Infused System, Amanda Smolock, MD, PhD, Medical College of Wisconsin
  • Radiomics-based predictive models for new intrahepatic tumors following thermal ablation of colorectal liver metastasis, Iwan Paolucci, PhD, The University of Texas MD Anderson Cancer Center
  • Is the minimal ablative margin measured on intraprocedural post-ablation CT better than first follow-up CT in predicting colorectal liver metastasis outcomes? Yuan-Mao Lin, MD, The University of Texas MD Anderson Cancer Center
  • Circulating miR-21 as a prognostic biomarker for HCC treated with CT-guided high-dose rate brachytherapy, Matthias Stechele, MD, University Hospital, LMU Munich
  • An injectable intratumoral immunoadjuvant depot overcomes check-point inhibitor resistant cancer at distant tumor sites through local immune system stimulation, Avik Som, MD, PhD, MGH
  • MRI-guided trans-perineal focal cryoablation for primary prostate cancer, Aliza Mushtaq, MD, Mayo Clinic
  • Immediate 3D Imaging Assessment is the Most Accurate Predictor of Local Tumor Progression after Microwave Ablation of CRC Liver Metastases, Mahdi Zirakchian Zadeh, MD, Memorial Sloan Kettering Cancer Center
  • Development of Patient-Derived Hepatocellular Carcinoma (HCC) Tumoroids as a Platform for Preclinical Investigations of Liver-Directed Therapies, Christopher Malone, MD, Mallinckrodt Institute of Radiology at Washington University School of Medicine
11:00am - 11:30am

Expo Hall Break - Discovery Theater Presentation by Varian, a Siemens Healthineers Company

Image-Guided Cryoablation and Embolization in MSK: MSK Intervention with Cryotherapy and Embolization Using Integrated Angio-CT Solutions, Rahul Anil Sheth, MD

11:30am - 12:30pm

Managing Post-Treatment & Surgical Complications: M&M

Moderators: Anne Covey, MD, Memorial Sloan Kettering Cancer Center; Kirema Garcia-Reyes, MD, Mount Sinai Hospital

  • Hepatobiliary Interventions: Surgeon Perspective, Betsy King, MD, PhD, Johns Hopkins University
  • Hepatobiliary Interventions: IR Perspective, Lynn Brody, MD, Memorial Sloan Kettering Cancer Center
  • GU Interventions Post-Ablation: IR Perspective, Andrew Taylor, , MD, PhD, University of California San Francisco 
  • Lymphatic Interventions: Not Out of Sight Out of Mind, Maxim Itkin, MD, University of Pennsylvania

Palliative Care Case Examples

Moderators: Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens; Nicholas Fidelman, MD, University of California San Francisco

  • Vertebral Augmentation, Ablation & Bone Pain, Steven Yevich, MD, MPH, MD Anderson Cancer Center
  • Nerve AblationDimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens
  • PTEG, Gina Landinez, MD, University of California San Francisco
  • Electro-Chemotherapy for Tumors with Epidural ExtensionFrederic Deschamps, MD, PhD, Gustave Roussy

Liver Directed Therapy for Early Stage HCC

Moderators: Kelvin Hong, MD, Johns Hopkins University; Laura Crocetti, MD, PhD, University of Pisa

  • Surgical Approach, Andrew Cameron, MD, PhD, Johns Hopkins University
  • Arterial Approach, Kelvin Hong, MD, Johns Hopkins University
  • AblationLaura Crocetti, MD, PhD, University of Pisa
  • Radiation Oncology, Amol Narang, MD, Johns Hopkins University
12:30pm - 12:45pm Break
12:45pm - 1:30pm

Lunch & Industry Symposium Presented by TriSalus - Interventional Immunotherapy for Liver and Pancreatic Tumors: Updates from PERIO Trials

  • Steven Katz, MD, FACS, TriSalus Life Sciences
  • Alex Kim, MD, National Vascular Physicians
  • Rahul Sheth, MD, MD Anderson Cancer Center

Lunch & Industry Symposium Presented by Sirtex - Resin Y-90 Dosimetry: From Theory to Practice

  • S. Cheenu Kappadath, PhD, MD Anderson Cancer Center
  • Nima Kokabi, MD, FRCP, Emory University

1:30pm - 2:00pm

Expo Hall Afternoon Hours - Discovery Theater Presentation by Varian, a Siemens Healthineers Company

Is Access to Interventional Oncology Care in the US Equitable? Geographic Access to Interventional Oncology Care in the USA, Theresa M. Caridi, MD, FSIR

2:00pm - 3:00pm

Women & Under-Represented Minorities in IO

Moderators: Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health

  • Setting the Stage, Brad Wood, MD, NIH; Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
  • Changing the Pipeline, Culture & Environment, Amy Deipolyi, MD, PhD, West Virginia University & Sherri Reed, Research Fellow, NIH
  • Pigeonholing & Imposter SyndromeMaureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill & Kirema Garcia-Reyes, MD, Mount Sinai Hospital
  • He for She & Male PortraitureBrad Wood, MD, NIH & Nicole Varble, NIH
  • Panel Discussion

Planning Committee: Maureen Kohi, MD, FSIR, FCIRSE, FAHA, University of North Carolina at Chapel Hill; Ji Buethe, MD, Johns Hopkins University; Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center; Erica Alexander, MD, Memorial Sloan Kettering Cancer Center; Sharon Kwan, MD, MS, Seattle Cancer Care Alliance

3:00pm - 4:00pm

Expo Hall Networking & Oral Poster Presentations

  • Fusion-Guided Optical Molecular Imaging Liver Biopsy and Point-of-Care Tissue Assessment for Liver Neoplasms, Michael Kassin, MD, NIH
  • Microwave Ablation of Stage IA Non-Small Cell Lung Cancers Detected at Low Dose CT Lung Cancer Screening in US Veterans: Midterm Results, Ericson John Torralba, Wright State University Boonshoft School of Medicine
  • Rapid Diagnosis through IR Outpatient Clinic to Expedite Triage for Patients without a Cancer Diagnosis and Diffuse Imaging Findings Suggestive of Cancer, Suken Shah, MD, Memorial Sloan Kettering Cancer Center
4:00pm - 5:00pm

Hands-On: Navigation & Guidance

Sarcoma

Moderators: Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center; Jack Jennings, MD, PhD, Washington University St. Louis

  • Sarcoma & Immunotherapy, Peter Rydesky, MD, Rochester Radiology Associates
  • What Ablation Can Add to Systemic & Immuno Therapy, Christian Meyer, MD, PhD, MS, Johns Hopkins University
  • Intratumor Injections & Immunotherapy, Rahul Sheth, MD, MD Anderson Cancer Center
  • Update on Ablation for Sarcoma Data Outcomes, Florian Fintelmann, MD, Massachusetts General Hospital

Breast

Moderators: Kenneth Tomkovich, MD, Princeton; Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center

  • Current Status, Yolanda Bryce, MD, Memorial Sloan Kettering Cancer Center
  • Patient Selection & Indications for Ablation in BreastKenneth Tomkovich, MD, Princeton
  • Cryo, Robert Ward, MD, Brown University
  • New Horizons in Breast Intervention, Peter Littrup, MD, Ascension Providence Rochester Hospital
  • Treatment of Metastatic Disease, Amy Diepolyi, MD, PhD, West Virginia University
5:00pm - 5:15pm Break
5:15pm - 6:15pm

GU/Bone Tumor Board

Moderators: Matthew Callstrom, MD, PhD, Mayo Clinic; Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, University of Athens

Panelists: David Einstein, MD, Beth Israel Deaconess Medical Center; Steven Yevich, MD, MPH, MD Anderson Cancer Center; Damian DupuyMD, FACR, Cape Cod Hospital

5:45pm - 6:45pm Industry Members' Reception (by invitation only)
8:30pm - 10:30pm SIO Presents: DC After Dark - Trivia & Networking

Sunday 22 January 2023

Time (EST)

Session Title(s)

8:00am - 9:00am Expo Hall Morning Hours
9:00am - 10:00am

HCC New Horizons

  • Introduction & Laudation, Julius Chapiro, MD, PhD, Yale University School of Medicine
  • HCC New Horizons Keynote, David Madoff, MD, Yale School of Medicine
10:00am - 11:00am

Scientific Oral Abstracts

Moderators: Brad Wood, MD, NIH; Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; Dimitrios Filippiadis, MD, PhD, MSc, EBIR, University of Athens

  • Effect of injection rate on bead distribution and volume delivered during embolization in swine: Results from the AmCORE, Antonio Arrichiello, MD, National Institutes of Health
  • Optimizing patient selection for treating colorectal liver metastases with glass radioembolization plus chemotherapy: The EPOCH study, Riad Salem, MD, MBA, Northwestern University
  • Phase I Prospective Trial of TAS-102 (trifluridine and tipiracil) and Radioembolization for Chemo-refractory Colorectal Liver Metastases, Nicholas Fidelman, MD, University of California San Francisco
  • Enhanced Delivery of a TLR9 Type C Agonist SD-101 to Liver Tumors in the Oncopig using Pressure Enabled Drug Delivery (PEDD) Versus a Standard Endhole Catheter, Thomas Hullinger, PhD, TriSalus Life Sciences
  • Radiofrequency ablation induced tumor growth is suppressed by microRNA21 inhibition, Lukas Salvermoser, MD, University Hospital Munich
  • MRI Radiomics Correlate with Clinical Outcomes of Peripheral Venous Malformations Following Percutaneous Sclerotherapy, Adham Khalil, MD, Johns Hopkins University
  • Does Cancer Type Influence the Rate of Port Associated Infection? Alirezsa Zandifar, MD, Children's Hospital of Philadelphia
11:00am - 11:30am

Expo Hall Break - Discovery Theater Presentation by XACT Robotics

Advancements in Robotic Percutaneous Procedures, Francois H. Cornelis, MD, PhD

11:30am - 12:30pm

MSK

Moderators: Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego; Alan Alper Sag, MD, Duke University Medical Center

  • Desmoids, Marwan Moussa, MD, Beth Israel Deaconess Medical Center
  • Cement & Screws: Evidence, Sean Tutton, MD, FSIR, FCIRSE, University of California San Diego
  • Pre-Surgical Embolization, Rahul Sheth, MD, MD Anderson Cancer Center
  • Pain PalliationNeil J. Resnick, MD, Emory University
  • MSK Pain Palliation: Anesthesiologist Perspective, Allan Gottschalk, MD, PhD, Johns Hopkins University

Combination Therapies

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Nicholas Fidelman, MD, University of California San Francisco

  • Combination with Immunotherapy, Lambros Tselikas, MD, Gustave Roussy
  • Lung: Endobronchial Techniques, Matt Kinsey, MD, University of Vermont Medical Center
  • LDT in Combination with Targeted Agents for HCC, Ammar Sarwar, MD, FSIR, Beth Israel Deaconess Medical Center/Harvard Medical School
  • Y90 in Combination with Radiosensitizing ChemotherapyNicholas Fidelman, MD, University of California San Francisco
  • Combination Radiotherapy & Ablative Techniques for Lung Cancer, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania

Combined Locoregional & Immunotherapy of HCC Grant Update

Moderator: Julius Chapiro, MD, PhD, Yale University School of Medicine

  • SIO Grant Program ReportJulius Chapiro, MD, PhD, Yale University School of Medicine
  • Single Cell Analysis of Combined Thermal Ablation and Immunotherapy of HCC, Prof. S. Nahum Goldberg, MD, Hadassah Hebrew University Medical Center
  • Engineered Extracellular Vesicles to Modulate Immunotherapy in Liver Cancer, Kiyoyuki Minamiguchi, MD, MD Anderson Cancer Center
  • Stoking an Anti-Liver Cancer Immune Response with Cryoablation Plus Intratumoral Immunostimulant, Isabel Newton, MD, PhD, VA San Diego Healthcare System & UC San Diego Health
  • Immunobiologic and Metabolic Determinants of Response to Combination Locoregional and Immunotherapy in HCC, Kelley Weinfurtner, MD, University of Pennsylvania
12:30pm - 12:45pm Break
12:45pm - 1:30pm

Lunch & Industry Symposium Presented by AstraZeneca - Newly Approved Treatment Options for Unresectable Hepatocellular Carcinoma 

  • Bassam Estfan, MD, Cleveland Clinic

Lunch & Education Session - HCC Imaging and Chemoembolization 2023: New Techniques, New Science

Moderator: Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania

  • Latest Guidelines and Randomized Trials, Lambros Tselikas, MD, Gustave Roussy
  • Biomarkers in Liver Cancer TherapyJulius Chapiro, MD, PhD, Yale University School of Medicine
1:30pm - 2:00pm

Expo Hall Afternoon Hours - Discovery Theater Presentation by Instylla

Embrace (TM) HES for Tumor Embolization, Stephen Hunt, MD

2:00pm - 3:00pm

AI

Moderators: Julius Chapiro, MD, PhD, Yale University School of Medicine; Joseph Erinjeri, MD, PhD, Memorial Sloan Kettering Cancer Center

  • Publishing AI Research: What an Author Needs to Know, Iwan Paolucci, PhD, MD Anderson Cancer Center
  • AI in Interventional Oncology: Top 10 Papers, Lynne Martin, MD, Stanford University
  • Public Databases and Data Policies: An Overview, Lynn Savic, MD, Universitatsmedizin Charite Berlin
  • Learning the Language of AI: How I Do It as an MD, Aaron Abajian, MD, MS, Memorial Sloan Kettering Cancer Center
  • Building Academic-Industrial Partnerships in AI, Rajesh Shah, MD, Stanford University

Lung Cancer & Mets

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Alda Tam, MD, MD Anderson Cancer Center

  • Cutting Edge Clinical Trials in Lung AblationAlda Tam, MD, MD Anderson Cancer Center
  • Combination Immunotherapy, Stephen Hunt, MTR, MD, PhD, University of Pennsylvania
  • Oligonodular Disease: Changing LandscapeMuneeb Ahmed, MD, Beth Israel Deaconess Medical Center/Harvard
  • Thermal Therapy Considerations, Beau Toskich, MD, Mayo Clinic
  • Hot Topics in Trial Design for Minimally Invasive ProceduresFlorian Fintelmann, MD, Massachusetts General Hospital

Head, Neck & Neuro

Moderators: Frederic Deschamps, MD, PhD, Gustave Roussy; Rony Avritscher, MD, MD Anderson Cancer Center

  • Laser Ablation for Head & Neck Tumors, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
  • Y90 for GBM, Riad Salem, MD, MBA, Northwestern University
  • Lipiodol for Head & Neck Tumors, Kazim Narsinh, MD, University of California San Francisco
3:00pm - 4:00pm

Expo Hall Networking & Oral Poster Presentations

  • Clinical Feasibility of CT-based Dosimetry in Yttrium-90 Radioembolization Following the Administration of Radiopaque Glass Microspheres (Eye90), Robert Abraham, MD, Dalhousie University
  • Targeting for Transcostal Histotripsy: Effect of Intervening Ribs on the Location of Cavitation, Katrina Falk, MS, University of Wisconsin-Madison
  • Temporary Transvenous Pacer to Avoid Hypertensive Crisis during Percutaneous Ablation of Adrenal Metastasis: a single-center experience, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
4:00pm - 5:00pm

Hands-On: Treatment Planning & Simulations

Liver Mets

Moderator: Edward Kim, MD, Mount Sinai Health Systems; Nora Tabori, MD, MedStar

  • Y90 for Liver Mets, Edward Kim, MD, Mount Sinai Health Systems
  • Latest Radioembolization Trials for Colorectal Cancer, Mary Mulcahy, MD, Northwestern University
  • Updates on Neuroendocrine, Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania
  • Combination Approaches to Metastatic DiseaseNicholas Fidelman, MD, University of California San Francisco

Prostate

Moderators: Vijay Ramalingam, MD, Beth Israel Deaconess Medical Center; David Woodrum, MD, PhD, Mayo Clinic

  • Current Status of Prostate Cancer, Lance Mynderse, MD, Mayo Clinic
  • Prostate AnatomyDavid Woodrum, MD, PhD, Mayo Clinic
  • CT-Guided Treatment for Prostate CancerVijay Ramalingam, MD, Beth Israel Deaconess Medical Center
  • MRI-Guided Laser Therapy for Prostate Cancer Treatment, Eric Walser, MD, University of Texas Medical Branch
  • Prostate Imaging, Daniel Adamo, MD, Mayo Clinic
5:00pm - 5:15pm Break
5:15pm - 6:15pm

Liver Mets Tumor Board

Moderators: Edward Kim, MD, Mount Sinai Health Systems; Nora Tabori, MD, MedStar

Panelists: Kelly Lafaro, Md, Johns Hopkins University; Mary Mulcahy, MD, Northwestern University; Michael Soulen, MD, FSIR, FCIRSE, University of Pennsylvania; Nicholas Fidelman, MD, University of California San Francisco; Bruno Odisio, MD, FSIR, MD Anderson Cancer Center

6:15pm - 7:00pm Break
7:00pm - 9:00pm Sunday Soiree Jack Rose Dining Saloon*
Social Event attendance requires an additional fee.

Monday 23 January 2023

Time (EST)

Session Title(s)

9:00am - 10:00am

Technology

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; Joseph Amaral, MD, Histosonics Institute

  • Pulsed Electric FieldsStephen Hunt, MTR, MD, PhD, University of Pennsylvania
  • Histotripsy, Timothy Ziemlewicz, MD, UW Madison
  • Robotic Endoscopy for Lung CancerMichael Pritchett, DO, MPH, Pinehurst Medical
  • Bronchoscopic Lung Microwave Ablation, Michael Pritchett, DO, MPH, Pinehurst Medical
  • Treatment Planning, Punit Prakash, PhD, Kansas State University
10:00am - 10:15am Break
10:15am - 12:15pm

Case-Based Review

Moderators: Damian Dupuy, MD, FACR, Cape Cod Hospital; R. Peter Lokken, MD, MPH, FSIR University of California San Francisco

  • Liver Embolization, Christos Georgiades, MD, PhD, Johns Hopkins University
  • Liver Ablation, Bruno Odisio, MD, FSIR, MD Anderson Cancer Center
  • RenalRyan Kohlbrenner, MD, University of California San Francisco
  • LungJi Buethe, MD, Johns Hopkins University
  • MSK, A. Nick Kurup, MD, Mayo Clinic
  • Complications: MissR. Peter Lokken, MD, MPH, FSIR University of California San Francisco
  • Complications: Save, Stephen Solomon, MD, Memorial Sloan Kettering Cancer Center
12:15pm - 12:30pm

Closing Remarks

Matthew Callstrom, MD, PhD, Mayo Clinic